Acarodermatitis and drugs of ingredients of naproxen (a real world drug study)
Summary:
Acarodermatitis is found among people who take drugs with ingredients of naproxen, especially for people who are female, 40-49 old , have been taking the drugs for < 1 month. This phase IV clinical study is created by eHealthMe based on reports of 84,606 people who have side effects when taking drugs with ingredients of naproxen from the FDA, and is updated regularly.
Drug(s) considered in the study (i.e. both brand name and generic drugs): Ec-naprosyn, Naprosyn, Naproxen.
84,606 people reported to have side effects when taking drugs with ingredients of naproxen.
Among them, 25 people (0.03%) have Acarodermatitis
What is Acarodermatitis?
Acarodermatitis (skin inflammation caused by mites (acarids)) is found to be associated with 221 drugs and 310 conditions by eHealthMe. Check the latest studies of Acarodermatitis.
Number of reports submitted per year:

Time on drugs with ingredients of naproxen when people have Acarodermatitis *:
- < 1 month: 92.86 %
- 1 - 6 months: 7.14 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Gender of people who have Acarodermatitis when taking drugs with ingredients of naproxen *:
- female: 96 %
- male: 4 %
Age of people who have Acarodermatitis when taking drugs with ingredients of naproxen *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 4.55 %
- 20-29: 4.55 %
- 30-39: 4.55 %
- 40-49: 59.09 %
- 50-59: 27.27 %
- 60+: 0.0 %
Conditions people have *:
You may use this to check any potential undetected conditions.
- Urinary Tract Infection: 21 people, 84.00%
- Cellulitis (infection under the skin): 20 people, 80.00%
- Juvenile Rheumatoid Arthritis (joint inflammation in children due to systemic disease): 18 people, 72.00%
- Still's Disease Adult Onset (a rare illness that causes high fevers, rash, and joint pain in adult just started): 4 people, 16.00%
- Bipolar Disorder (mood disorder): 2 people, 8.00%
- Insomnia (sleeplessness): 1 person, 4.00%
- Hyperchlorhydria (gastric acid levels are higher in stomach): 1 person, 4.00%
- Burning Sensation: 1 person, 4.00%
- Affective Disorder (mental disorder): 1 person, 4.00%
Other drugs people take *:
You may use this to check any potential interacting drugs.
- Celebrex: 22 people, 88.00%
- Actemra: 21 people, 84.00%
- Arava: 21 people, 84.00%
- Cymbalta: 20 people, 80.00%
- Allegra: 20 people, 80.00%
- Codeine: 16 people, 64.00%
- Macrobid: 14 people, 56.00%
- Omega 3: 12 people, 48.00%
- Vitamin C: 10 people, 40.00%
- Eucrisa: 10 people, 40.00%
Other side effects people have besides Acarodermatitis *:
You may use this to check any potential undetected side effects.
- Nausea (feeling of having an urge to vomit): 23 people, 92.00%
- Rashes (redness): 22 people, 88.00%
- Upper Respiratory Tract Infection: 22 people, 88.00%
- Weight Increased: 22 people, 88.00%
- Drug Hypersensitivity: 22 people, 88.00%
- White Blood Cells Urine Positive: 21 people, 84.00%
- Joint Range Of Motion Decreased (disease of joint movement): 21 people, 84.00%
- Oral Herpes (viral infection of mouth): 21 people, 84.00%
- Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 21 people, 84.00%
- Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 21 people, 84.00%
* Approximation only. Some reports may have incomplete information.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies
Drugs with ingredients of naproxen, their effectiveness, alternatives and more:
How the study uses the data?
The study uses data from the FDA. It is based on naproxen. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Furosemide and Atrial Fibrillation/Flutter for Girls aged 2-9 - a second ago
- Furosemide and Heart Fibrillation for Girls aged 2-9 - 2 seconds ago
- Ceftriaxone and Cardiac Failure Congestive for Men aged 60+ - 2 seconds ago
- Furosemide and Atrial Flutter for Girls aged 2-9 - 2 seconds ago
- Furosemide and Auricular Fibrillation for Girls aged 2-9 - 2 seconds ago
- Furosemide and A-Fib for Girls aged 2-9 - 3 seconds ago
- Furosemide and Atrial Fibrillation for Girls aged 2-9 - 3 seconds ago
- Could Furosemide cause Bladder Outlet Obstruction? - 6 seconds ago
- Drug interactions of Isentress and Metolazone - 8 seconds ago
- Gemcitabine and Hair Loss for Women aged 50-59 - 13 seconds ago